Skip to content

GB SCIENCES INC: 10-Q filed 2023-11-20

What GB SCIENCES INC reported in its quarterly report filed 2023-11-20 (fiscal Q2 2024): 36 published measures, 104 facts as tagged in accession 0001437749-23-032645.

This filing

Form
10-Q (quarterly report)
Filed
2023-11-20
Fiscal period
fiscal Q2 2024
Accession
0001437749-23-032645 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All GB SCIENCES INC filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2023-09-30234,185USD
At 2022-12-31352,323USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2023-09-304,927,311USD
At 2022-12-314,759,706USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2023-09-30-4,693,126USD
At 2022-12-31-4,407,383USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2023-09-30104,530USD
At 2022-12-31109,912USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2023-07-01 to 2023-09-30-434,233USD92
2023-04-01 to 2023-09-30-707,354USD183
2022-07-01 to 2022-09-30-313,057USD92
2022-04-01 to 2022-09-30-811,146USD183

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2023-04-01 to 2023-09-30-517,825USD183
2022-04-01 to 2022-09-30-907,564USD183

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2023-07-01 to 2023-09-300USD92
2023-04-01 to 2023-09-300USD183
2022-07-01 to 2022-09-300USD92
2022-04-01 to 2022-09-300USD183

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2023-04-01 to 2023-09-30277,443USD183
2022-04-01 to 2022-09-301,361,745USD183

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2023-04-01 to 2023-09-30235,000USD183
2022-04-01 to 2022-09-30-30,320USD183

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2023-09-30-109,412,669USD
At 2022-12-31-108,705,315USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2023-07-01 to 2023-09-30395,738,723shares92
2023-04-01 to 2023-09-30388,843,528shares183
2022-07-01 to 2022-09-30346,269,298shares92
2022-04-01 to 2022-09-30336,062,449shares183

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2023-07-01 to 2023-09-300USD/shares92
2023-04-01 to 2023-09-300USD/shares183
2022-07-01 to 2022-09-300USD/shares92
2022-04-01 to 2022-09-300USD/shares183

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2023-07-01 to 2023-09-300USD92
2023-04-01 to 2023-09-300USD183
2022-07-01 to 2022-09-300USD92
2022-04-01 to 2022-09-300USD183

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2023-04-01 to 2023-09-30219,168USD183
2022-04-01 to 2022-09-3013,000USD183

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2023-07-01 to 2023-09-30-551,491USD92
2023-04-01 to 2023-09-30-816,614USD183
2022-07-01 to 2022-09-30-275,839USD92
2022-04-01 to 2022-09-30-735,357USD183

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2023-09-30234,185USD
At 2022-12-31309,504USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2023-07-01 to 2023-09-3042,742USD92
2023-04-01 to 2023-09-3083,546USD183
2022-07-01 to 2022-09-3037,218USD92
2022-04-01 to 2022-09-3075,789USD183

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2023-09-304,852,311USD
At 2022-12-314,759,706USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2023-09-300USD
At 2022-12-3142,819USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2023-07-01 to 2023-09-300USD92
2023-04-01 to 2023-09-300USD183
2022-07-01 to 2022-09-300USD92
2022-04-01 to 2022-09-300USD183

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2023-07-01 to 2023-09-300USD92
2023-04-01 to 2023-09-300USD183
2022-07-01 to 2022-09-300USD92
2022-04-01 to 2022-09-300USD183

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2023-09-30402,737,695shares
At 2022-12-31381,872,561shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2023-09-30104,679,155USD
At 2022-12-31104,259,745USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2023-09-30-4,693,126USD
At 2023-06-30-4,680,504USD
At 2023-03-31-4,407,383USD
At 2022-09-30-1,193,368USD
At 2022-06-30-2,165,711USD
At 2022-03-31-1,782,872USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2023-09-3075,628USD
At 2022-12-3175,628USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2023-09-30129,655USD
At 2022-12-31199,592USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2023-07-01 to 2023-09-30-434,233USD92
2023-04-01 to 2023-09-30-707,354USD183
2022-07-01 to 2022-09-30-313,057USD92
2022-04-01 to 2022-09-30-811,146USD183

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2023-04-01 to 2023-09-30-707,354USD183
2022-04-01 to 2022-09-30-811,146USD183

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2023-07-01 to 2023-09-30-703,451USD92
2023-04-01 to 2023-09-30-976,572USD183
2022-07-01 to 2022-09-30-313,057USD92
2022-04-01 to 2022-09-30-811,146USD183

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2023-07-01 to 2023-09-30551,491USD92
2023-04-01 to 2023-09-30816,614USD183
2022-07-01 to 2022-09-30275,839USD92
2022-04-01 to 2022-09-30735,357USD183

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2023-04-01 to 2023-09-30624USD183
2022-04-01 to 2022-09-3040,492USD183

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2023-07-01 to 2023-09-30160,000USD92
2023-04-01 to 2023-09-30235,000USD183
2022-07-01 to 2022-09-300USD92
2022-04-01 to 2022-09-300USD183

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2023-07-01 to 2023-09-30117,258USD92
2023-04-01 to 2023-09-30109,260USD183
2022-07-01 to 2022-09-30-37,218USD92
2022-04-01 to 2022-09-30-75,789USD183

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2023-04-01 to 2023-09-300USD183
2022-04-01 to 2022-09-300USD183

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2023-04-01 to 2023-09-300USD183
2022-04-01 to 2022-09-301,595,000USD183

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2023-04-01 to 2023-09-309,060USD183
2022-04-01 to 2022-09-30-102,254USD183

Inspect the source

Entity
GB SCIENCES INC / CIK 0001165320
Captured
2026-09-21T17:18:52.310Z
SEC response SHA-256
12b1d1f0b357f0e2b89807866d8015ff01521dc77cf9434cd2743e05e167f8a9

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001165320.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))